Teva Pharma (TEVA) Reports In-Line Q2 EPS; Lowers Revenue Outlook
Go back to Teva Pharma (TEVA) Reports In-Line Q2 EPS; Lowers Revenue Outlook| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 33.08 +0.88 (2.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.20 | 52 Week High | $66.55 | |||
| Open | $32.14 | 52 Week Low | $37.82 | |||
| Day High | $33.26 | P/E | N/A | |||
| Day Low | $32.12 | EPS | $0.00 | |||
| Volume | 1,943,098 | |||||
